Skip to content

Sera Prognostics SERA Cost not yet recognized

Cost not yet recognized at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M+5.0%
Enterprise value$69.6M+9.6%
P/S1,250.3×+622×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's cost not yet recognized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's cost not yet recognized?
Sera Prognostics (SERA) reported cost not yet recognized of $1.9M in Q1 2026.
How has Sera Prognostics's cost not yet recognized changed year-over-year?
Sera Prognostics's cost not yet recognized decreased by 18.2% year-over-year, from $2.32M to $1.9M.
What is the long-term trend for Sera Prognostics's cost not yet recognized?
Over 3 years (2021 to 2024), Sera Prognostics's cost not yet recognized has grown at a -45.5% compound annual growth rate (CAGR), from $12.2M to $1.98M.